Synergistic growth inhibition by acyclic retinoid and phosphatidylinositol 3-kinase inhibitor in human hepatoma cells

BACKGROUND: A malfunction of RXRα due to phosphorylation is associated with liver carcinogenesis, and acyclic retinoid (ACR), which targets RXRα, can prevent the development of hepatocellular carcinoma (HCC). Activation of PI3K/Akt signaling plays a critical role in the proliferation and survival of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Baba, Atsushi, Shimizu, Masahito, Ohno, Tomohiko, Shirakami, Yohei, Kubota, Masaya, Kochi, Takahiro, Terakura, Daishi, Tsurumi, Hisashi, Moriwaki, Hisataka
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2013
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3852533/
https://ncbi.nlm.nih.gov/pubmed/24103747
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-465
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars